tiprankstipranks

William James Kennedy Insider Profile

18 Followers
William James Kennedy, Director at TG Therapeutics, holds 109.63K shares in TG Therapeutics (Ticker: TGTX), holds 0.00 shares in X T L Biopharmaceuticals (Ticker: XTLB).
tipranks
William James Kennedy

William James Kennedy
TG Therapeutics (TGTX)
Director

Ranked #39,006 out of 78,624 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+0.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
0.00%
A breakdown of William James Kennedy's holdings

Insider Roles

TG Therapeutics
(TGTX)
Director
X T L Biopharmaceuticals
(XTLB)
Director
Roles that William James Kennedy holds in companies

Most Profitable Insider Trade

Stock:
TG Therapeutics
(TGTX)
Rating:Informative Sell
Date:Jul 09, 2015 - Jul 09, 2016
Return:+66.00%
The most profitable trade made by William James Kennedy

William James Kennedy's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TG Therapeutics
Jun 24, 2020
Director
Uninformative Sell
$3.32M
X T L Biopharmaceuticals
Director
$0.00
List of latest transactions for each holding click on a transaction to see William James Kennedy's performance on stock

William James Kennedy insider profile FAQ

What is the percentage of profitable transactions made by William James Kennedy?
The percentage of profitable transactions made by William James Kennedy is 50%.
    What is the average return per transaction made by William James Kennedy?
    The average return per transaction made by William James Kennedy is 0.10%.
      What stocks does William James Kennedy hold?
      William James Kennedy holds: TGTX, XTLB stocks.
        What was William James Kennedy’s latest transaction?
        William James Kennedy latest transaction was an Uninformative Sell of ―.
          What was William James Kennedy's most profitable transaction?
          William James Kennedy’s most profitable transaction was an Informative Sell of TGTX stock on July 9, 2015. The return on the trade was 66.00%.
            What is William James Kennedy's role in TG Therapeutics?
            William James Kennedy's role in TG Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.